IT1245889B - Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari. - Google Patents

Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari.

Info

Publication number
IT1245889B
IT1245889B ITBO910112A ITBO910112A IT1245889B IT 1245889 B IT1245889 B IT 1245889B IT BO910112 A ITBO910112 A IT BO910112A IT BO910112 A ITBO910112 A IT BO910112A IT 1245889 B IT1245889 B IT 1245889B
Authority
IT
Italy
Prior art keywords
gastro
resistant
pharmaceutical formulations
tablets
oral use
Prior art date
Application number
ITBO910112A
Other languages
English (en)
Inventor
Egidio Marchi
Gianfranco Tamagnone
Leone Gabriele Rotini
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Publication of ITBO910112A0 publication Critical patent/ITBO910112A0/it
Priority to ITBO910112A priority Critical patent/IT1245889B/it
Priority to US07/861,461 priority patent/US5302398A/en
Priority to EP92105714A priority patent/EP0510404B1/en
Priority to DE69212882T priority patent/DE69212882T2/de
Priority to TW081102516A priority patent/TW202389B/zh
Priority to ES92105714T priority patent/ES2090394T3/es
Priority to DK92105714.7T priority patent/DK0510404T3/da
Priority to JP4091129A priority patent/JP2509044B2/ja
Priority to CA002065809A priority patent/CA2065809C/en
Priority to KR1019920006051A priority patent/KR970005175B1/ko
Publication of ITBO910112A1 publication Critical patent/ITBO910112A1/it
Application granted granted Critical
Publication of IT1245889B publication Critical patent/IT1245889B/it
Priority to GR960402160T priority patent/GR3020843T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Formulazioni farmaceutiche per uso orale ricoperte da una pellicola gastroresistente enterosolubile, preferibilmente scelte tra granulati gastroresistenti, compresse gastroresistenti, capsule gastroresistenti di gelatina dura contenenti polveri o granulati o due o più compresse o sospensioni oleose, capsule gastroresistenti di gelatina molle contenenti sospensioni oleose e capsule di gelatina dura contenenti granulati gastroresistenti o due o più compresse gastroresistenti, contenenti quantità terapeuticamente efficaci di sali degli acidi biliari con metalli alcalini o con basi organiche, processo per la loro preparazione e loro uso terapeutico nel trattamento delle calcolosi biliari, delle dispepsie biliari, della cirrosi biliare e delle epatopatie croniche e colestatiche.
ITBO910112A 1991-04-12 1991-04-12 Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari. IT1245889B (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
ITBO910112A IT1245889B (it) 1991-04-12 1991-04-12 Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari.
US07/861,461 US5302398A (en) 1991-04-12 1992-04-01 Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids
DK92105714.7T DK0510404T3 (da) 1991-04-12 1992-04-02 Gastroresistente farmaceutiske formuleringer til oral administration indeholdende galdesyresalte
DE69212882T DE69212882T2 (de) 1991-04-12 1992-04-02 Gallensäuresalze enthaltende magenstabile pharmazeutische Zusammensetzung zur oralen Verabreichung
TW081102516A TW202389B (it) 1991-04-12 1992-04-02
ES92105714T ES2090394T3 (es) 1991-04-12 1992-04-02 Formulados farmaceuticos gastroresistentes para administracion oral conteniendo sales de acidos biliares.
EP92105714A EP0510404B1 (en) 1991-04-12 1992-04-02 Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids
JP4091129A JP2509044B2 (ja) 1991-04-12 1992-04-10 胆汁酸塩を含有する胃液耐性のある経口投与用製剤
CA002065809A CA2065809C (en) 1991-04-12 1992-04-10 Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids
KR1019920006051A KR970005175B1 (ko) 1991-04-12 1992-04-11 담즙산의 염을 함유하는 경구용 위내성 의약 포뮬레이션
GR960402160T GR3020843T3 (en) 1991-04-12 1996-08-22 Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO910112A IT1245889B (it) 1991-04-12 1991-04-12 Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari.

Publications (3)

Publication Number Publication Date
ITBO910112A0 ITBO910112A0 (it) 1991-04-12
ITBO910112A1 ITBO910112A1 (it) 1992-10-12
IT1245889B true IT1245889B (it) 1994-10-25

Family

ID=11337388

Family Applications (1)

Application Number Title Priority Date Filing Date
ITBO910112A IT1245889B (it) 1991-04-12 1991-04-12 Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari.

Country Status (11)

Country Link
US (1) US5302398A (it)
EP (1) EP0510404B1 (it)
JP (1) JP2509044B2 (it)
KR (1) KR970005175B1 (it)
CA (1) CA2065809C (it)
DE (1) DE69212882T2 (it)
DK (1) DK0510404T3 (it)
ES (1) ES2090394T3 (it)
GR (1) GR3020843T3 (it)
IT (1) IT1245889B (it)
TW (1) TW202389B (it)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE171874T1 (de) * 1993-08-30 1998-10-15 Medichemie Ag Ursodeoxycholsäure enthaltendes arzneimittel in flüssiger darreichungsform
KR100578669B1 (ko) * 1997-05-29 2006-12-07 동아제약주식회사 우르소데옥시콜린산을함유하는투명연질캅셀
DE29717252U1 (de) * 1997-09-26 1998-02-19 Dr. Falk Pharma GmbH, 79108 Freiburg Arzneimittelkit aus einem Budesonid-haltigen und einem Ursodesoxycholsäure-haltigen Arzneimittel zur Behandlung von cholestatischen Lebererkrankungen
US7303768B2 (en) 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US20050158408A1 (en) * 1998-07-24 2005-07-21 Yoo Seo H. Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
CA2338457C (en) 1998-07-24 2009-11-17 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US7772220B2 (en) * 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
DE19906290A1 (de) * 1999-02-15 2000-08-17 Falk Pharma Gmbh Arzneimittel zur Behandlung bzw. Prävention von Darmkrebs
FR2796271B1 (fr) 1999-07-15 2002-01-11 Oreal Composition sans cire structuree sous forme rigide par un polymere
FR2796272B1 (fr) 1999-07-15 2003-09-19 Oreal Composition sans cire structuree sous forme rigide par un polymere
DE60019541T2 (de) * 1999-12-28 2006-03-09 L'oreal Strukturierte langhaltige Zubereitung enthaltend ein Polymer und pastöse Fettstoffe
FR2804018B1 (fr) 2000-01-24 2008-07-11 Oreal Composition sans transfert structuree sous forme rigide par un polymere
CN100558407C (zh) * 2000-02-04 2009-11-11 柳署弘 制备含有胆汁酸的澄清水溶液剂型
JP2002034198A (ja) * 2000-07-18 2002-01-31 Minebea Co Ltd スピンドルモータ
US8080257B2 (en) * 2000-12-12 2011-12-20 L'oreal S.A. Cosmetic compositions containing at least one hetero polymer and at least one film-forming silicone resin and methods of using
US6835399B2 (en) * 2000-12-12 2004-12-28 L'ORéAL S.A. Cosmetic composition comprising a polymer blend
US20020168335A1 (en) * 2000-12-12 2002-11-14 Nathalie Collin Cosmetic composition comprising a wax and a polymer
FR2817739B1 (fr) * 2000-12-12 2005-01-07 Oreal Composition cosmetique coloree transparente ou translucide
EP1343458B1 (fr) * 2000-12-12 2008-02-13 L'oreal Composition cosmetique comprenant un melange de polymeres
WO2002047623A1 (en) 2000-12-12 2002-06-20 L'oreal Sa Composition comprising at least one heteropolymer and at least one inert filler and methods for use
US6881400B2 (en) * 2000-12-12 2005-04-19 L'oreal S.A. Use of at least one polyamide polymer in a mascara composition for increasing the adhesion of and/or expressly loading make-up deposited on eyelashes
US20020107314A1 (en) * 2000-12-12 2002-08-08 Carlos Pinzon Compositions containing heteropolymers and oil-soluble esters and methods of using same
WO2002047626A1 (en) * 2000-12-12 2002-06-20 L'oreal Sa Cosmetic composition comprising heteropolymers and a solid substance and method of using same
FR2817740B1 (fr) * 2000-12-12 2006-08-04 Oreal Procede de fabrication d'une composition cosmetique coloree de maquillage a transmittance controlee
US7276547B2 (en) * 2000-12-12 2007-10-02 L'oreal S.A. Compositions comprising heteropolymers and at least one oil-soluble polymers chosen from alkyl celluloses and alkylated guar gums
WO2002047624A1 (en) * 2000-12-12 2002-06-20 L'oreal Sa Cosmetic compositions containing at least one heteropolymer and at least one gelling agent and methods of using the same
WO2002047628A1 (en) * 2000-12-13 2002-06-20 L'oréal Composition structured with a polymer containing a heteroatom and an organogelator
FR2819400B1 (fr) * 2001-01-15 2004-12-03 Oreal Composition cosmetique de maquillage ou de soin des matieres keratiniques comprenant un melange de polymeres
US7025953B2 (en) * 2001-01-17 2006-04-11 L'oreal S.A. Nail polish composition comprising a polymer
FR2819399B1 (fr) * 2001-01-17 2003-02-21 Oreal Composition cosmetique contenant un polymere et une huile fluoree
JP5502254B2 (ja) * 2001-01-31 2014-05-28 エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング 少なくとも２種類の異なる被覆ペレット形から成る多粒子剤形
US6716420B2 (en) * 2001-10-05 2004-04-06 L′Oreal Methods of use and of making a mascara comprising at least one coloring agent and at least one heteropolymer
FR2832060B1 (fr) * 2001-11-09 2004-07-09 Oreal Composition contenant un ester n-acyle d'acide amine et un filtre uv structuree par un polyamide
US6927071B2 (en) * 2001-12-07 2005-08-09 Beckman Coulter, Inc. Method for reducing non-specific aggregation of latex microparticles in the presence of serum or plasma
US20080057011A1 (en) * 2001-12-12 2008-03-06 L'oreal S.A., Composition structured with a polymer containing a heteroatom and an Organogelator
US20050008598A1 (en) 2003-07-11 2005-01-13 Shaoxiang Lu Cosmetic compositions comprising a structuring agent, silicone powder and swelling agent
US20040247549A1 (en) * 2002-06-12 2004-12-09 L'oreal S.A. Cosmetic emulsions containing at least one hetero polymer and at least one sunscreen and methods of using the same
US7008629B2 (en) * 2002-07-22 2006-03-07 L'ORéAL S.A. Compositions comprising at least one heteropolymer and fibers, and methods of using the same
US20040166133A1 (en) * 2003-01-21 2004-08-26 L'oreal Method of making a mascara composition comprising polyamide polymer and at least one solid substance having a melting point of 45oC or greater
US20040241252A1 (en) * 2003-05-29 2004-12-02 Abney Christopher Charles Pharmaceutical compositions for oral administration comprising lithium carbonate, processes of making the same, and methods of administering the same
US20040261311A1 (en) * 2003-06-13 2004-12-30 Mike Mattlage Fishing hook
US7145125B2 (en) * 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
ES2339790T3 (es) * 2004-08-30 2010-05-25 Seo Hong Yoo Efecto neuroprotector de udca solubilizado en modelo isquemico focal.
DE602005027727D1 (de) * 2004-10-15 2011-06-09 Seo Hong Yoo Zusammensetzungen zur verringerung der toxizität von cisplatin, carboplatin und oxaliplatin
EP1814558B1 (en) * 2004-11-01 2010-12-15 Seo Hong Yoo Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
US8865197B2 (en) * 2005-09-06 2014-10-21 Israel Oceanographic And Limnological Research Ltd. Food formulation for aquatic animals with integrated targeted delivery of bioactive agents
JP5856372B2 (ja) * 2008-02-20 2016-02-09 グノーシス・エツセ・ピー・アー 葉酸塩、これらの組成物および使用
WO2010080730A2 (en) * 2009-01-09 2010-07-15 Mayo Foundation For Medical Education And Research Methods and materials for delivering bile acids
KR20250008786A (ko) 2014-07-29 2025-01-15 센젠 하이타이드 바이오파마슈티컬 리미티드 베르베린 염, 우르소데옥시콜산 염 및 병용물, 이들의 제조 및 응용 방법
US20210046011A1 (en) 2019-08-12 2021-02-18 Massachusetts Institute Of Technology Articles and methods for administration of therapeutic agents
CN110898036A (zh) * 2019-12-18 2020-03-24 乐普制药科技有限公司 一种熊去氧胆酸缓释肠溶胶囊及其制备方法
AU2022261742A1 (en) * 2021-04-19 2023-11-02 Neurotrauma Sciences Llc Salts and crystalline forms of (3e) 3-[o-[(phosphonooxy)methyl]oxime]-pregn-4-ene-3, 20-dione and related uses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3634584A (en) * 1969-02-13 1972-01-11 American Home Prod Sustained action dosage form
FR2358144A1 (fr) * 1976-07-13 1978-02-10 Lipha Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
IT1101649B (it) * 1978-12-15 1985-10-07 Lehner Ag Composizione farmaceutica ad azione prolungata contenente acidi biliari
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
US4775536A (en) * 1986-02-24 1988-10-04 Bristol-Myers Company Enteric coated tablet and process for making
IT1212141B (it) * 1987-06-03 1989-11-08 So Ri Far S R L Composizioni farmaceutiche per la prevenzione e terapia della calcolosi delle vie biliari e della dispepsia biliare.
US4891223A (en) * 1987-09-03 1990-01-02 Air Products And Chemicals, Inc. Controlled release delivery coating formulation for bioactive substances
US5047258A (en) * 1989-07-14 1991-09-10 Sterling Drug Inc. Aqueous spray-coating process

Also Published As

Publication number Publication date
CA2065809A1 (en) 1992-10-13
DE69212882D1 (de) 1996-09-26
EP0510404B1 (en) 1996-08-21
DE69212882T2 (de) 1997-01-23
DK0510404T3 (da) 1996-09-09
US5302398A (en) 1994-04-12
GR3020843T3 (en) 1996-11-30
EP0510404A1 (en) 1992-10-28
CA2065809C (en) 1999-01-12
ITBO910112A1 (it) 1992-10-12
KR920019358A (ko) 1992-11-19
ITBO910112A0 (it) 1991-04-12
ES2090394T3 (es) 1996-10-16
JPH0597678A (ja) 1993-04-20
KR970005175B1 (ko) 1997-04-14
JP2509044B2 (ja) 1996-06-19
TW202389B (it) 1993-03-21

Similar Documents

Publication Publication Date Title
IT1245891B (it) Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali.
IT1245890B (it) Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
CA2065809A1 (en) Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids
EP3684418B1 (en) Compounds for the treatment of cysteamine sensitive disorders
DK0794794T3 (da) Fremgangsmåde, sammensætninger og sæt til forögelse af oral biotilgængelighed for farmaceutiske midler
BR9610480A (pt) Inibição do fator alfa de necrose tumoral
BG104620A (en) Oral pharmaceutical extended release dosage form
RU95110938A (ru) Производные 1-(2-оксоацетил)пиперидин-2-карбоновых кислот, фармацевтическая композиция, способ лечения, способ получения
NO962841D0 (no) Anvendelse av 2-hydroksy-5-fenylazobenzosyrederivater som colon cancer kjemopreventativer og kjemoterapeutiske midler
NO932979D0 (no) Orale doseringsformer med forsinket frigjoering for behandling av tarmforstyrrelser
DE69309540D1 (de) Orale Arzneimittel mit kolonspezifischer Freisetzung
IT1245761B (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.
ES2114562T3 (es) Forma de dosificacion para distribucion retardada de farmacos.
UA41995C2 (uk) Лікарська форма азитроміцину з контрольованим вивільненням ( варіанти ), спосіб її введення, спосіб її виготовлення і спосіб лікування інфекційних захворювань ссавців з її використанням ( варіанти )
TR199701117T1 (xx) Proton-ifrazat�n� -�nleyici maddeler i�eren farmas�tik bile�im.
NO890194L (no) Galenisk middel.
ES2172239T3 (es) Sistema osmotico de liberacion de farmacos.
NO995006L (no) Nye forbindelser
RU94045950A (ru) Фармацевтический препарат и способ его приготовления
AR011231A1 (es) Uso de un mejorador de sensibilidad a la insulina y composicion farmaceutica que comprende dicho mejorador
ATE260645T1 (de) Agitationsunabhängige pharmazeutische multiple- unit-retardzubereitungen und verfahren zu ihrer herstellung
TR199900336T2 (xx) EAA antagonistleri olarak tetrahidrokinolin t�revleri.
IT8720771A0 (it) Composizioni farmaceutiche per la prevenzione e terapia della calcolosi delle vie biliari e della dispepsia biliare.
DE60045114D1 (de) Zubereitungen zur Erhöhung der Bioverfügbarkeit von oral verabreichten pharmazeutischen Verbindungen
NO20025394D0 (no) Formuleringer inneholdende et glukokorticoid legemiddel for behandling av bronkopulmonire sykdommer

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960307